Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
11,015
+826
+8% +$96.7K 0.15% 84
2026
Q1
$1.23M Sell
10,189
-261
-2% -$30.1K 0.16% 78
2025
Q4
$1.1M Buy
10,450
+395
+4% +$37.1K 0.15% 86
2025
Q3
$844K Buy
10,055
+1,188
+13% +$97.8K 0.12% 104
2025
Q2
$717K Buy
8,867
+4,003
+82% +$318K 0.12% 113
2025
Q1
$437K Sell
4,864
-1,849
-28% -$173K 0.1% 117
2024
Q4
$676K Sell
6,713
-492
-7% -$50.7K 0.17% 80
2024
Q3
$818K Buy
7,205
+449
+7% +$53.3K 0.22% 68
2024
Q2
$836K Buy
6,756
+20
+0.3% +$2.58K 0.28% 58
2024
Q1
$889K Sell
6,736
-120
-2% -$14.8K 0.32% 57
2023
Q4
$747K Buy
6,856
+360
+6% +$37.4K 0.32% 62
2023
Q3
$669K Sell
6,496
-858
-12% -$92.5K 0.34% 62
2023
Q2
$799K Sell
7,354
-39
-0.5% -$4.43K 0.4% 53
2023
Q1
$787K Buy
7,393
+891
+14% +$96.2K 0.46% 46
2022
Q4
$721K Sell
6,502
-115
-2% -$11.8K 0.51% 49
2022
Q3
$570K Buy
+6,617
New +$591K 0.47% 56

Other funds holding MRK

FSM Wealth Advisors's MRK Position: Q2 2026 in Review

FSM Wealth Advisors increased its Merck (MRK) stake by 8.1% in Q2 2026, buying an estimated $96.7K and bringing the position to 11,015 shares worth $1.42M. The position accounts for 0.15% of the portfolio, ranked #84.

FSM Wealth Advisors first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • FSM Wealth Advisors held 11,015 shares of Merck worth $1.42M as of Q2 2026.
  • FSM Wealth Advisors bought 826 Merck shares in Q2 2026, an estimated $96.7K.
  • Merck made up 0.15% of FSM Wealth Advisors's portfolio in Q2 2026, its #84 holding.
  • FSM Wealth Advisors first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.